Evidence map›Paper›PMID 39045709›Full record

ArticleIntegrative cancer therapies

Measurement of Cognitive Function in Exercise Oncology Studies in Patients Treated With Chemotherapy: A Scoping Review.

Crisann Moon, Rebekah L Wilson, Paola Gonzalo-Encabo, Dong-Woo Kang, Sara Mithani, Christina M Dieli-Conwright, Darpan I Patel

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Crisann MoonUniversity of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Rebekah L WilsonDana-Farber Cancer Institute, Boston, MA, USA.
Paola Gonzalo-EncaboDana-Farber Cancer Institute, Boston, MA, USA.
Dong-Woo KangDana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0003-2292-1946
Sara MithaniUniversity of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Christina M Dieli-ConwrightDana-Farber Cancer Institute, Boston, MA, USA.
Darpan I PatelUniversity of Texas Medical Branch at Galveston, Galveston, TX, USA.ORCID 0000-0001-8124-8072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-associated cognitive deficits following chemotherapy have received increased attention in clinical research. Exercise has been shown to preserve cognitive function in cancer patients, though the overall effect is mixed. Here we present a scoping review of the published literature summarizing methods used to assess cognitive function in exercise oncology trials.

Indexed as

CognitionExerciseNeoplasmsAntineoplastic AgentsExercise TherapyHumansPatient Reported Outcome MeasuresAntineoplastic Agentsbreast cancercognitive impairmentexercisefatiguememoryoncologyphysical activityprostate cancerQigongresistance training

Identifiers

PMID39045709
PMCPMC11271141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.